PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

dupont-5-22-24-investor-presentation_vf-1 - DuPont | Presentation Nation

HomepageDuPontdupont-5-22-24-investor-presentation_vf-1

dupont-5-22-24-investor-presentation_vf-1

DuPont

Browse presentations, reports, and documents from DuPont.

Filter options

All (90)●
brochure (19)○
case-study (1)○
conference (1)○
documents (2)○
earnings (2)○
earnings_deck (1)○
infographic (26)○
investor_presentation (1)○
pitch-deck (1)○
presentation (35)○
whitepaper (1)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

dupont-5-22-24-investor-presentation_vf-1 by DuPont.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from DuPont

1Q-2024-DuPont-Earnings-Slides_vFINAL1

presentation

2015_DuPont_Pioneer_Seed_to_Harvest_Guide

infographic

Similar presentations from other companies

Concentra+Investor+Presentation+%28Q2-24%29

presentation

Concentra

Dexcom-Investor-Presentation_August-2023

presentation

DexCom

CommScope Holding Company_February_2018_682_21682

2Q-2023-DuPont-Earnings-Slides_vF

presentation

2Q-2024-DuPont-Earnings-Slides_vF

presentation

4Q-2022-DuPont-Earnings-Slides_vFINAL

presentation

4Q-2023-DuPont-Earnings-Slides_vFINAL1

presentation

presentation

CommScope

First Foundation__2023__938_94938

presentation

First Foundation Bank

CyberArk Software_August_2020_549_58549

presentation

CyberArk Software

Mirati Therapeutics_January_2020_367_50367

presentation

Mirati Therapeutics